Nitric oxide synthase: Non-canonical expression patterns

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Mattila, Joshua T ^a   Thomas, Anita C ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

eNOS; iNOS; Nitric oxide; Nitric oxide synthase; nNOS; NOS1; NOS2; NOS3

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ARTICLE; BIOCHEMISTRY; BLADDER CANCER; BONE MARROW DERIVED MACROPHAGE; BREAST CANCER; COLORECTAL CANCER; ENZYME ACTIVITY; EPIFLUORESCENCE MICROSCOPY; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MELANOMA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSLATION REGULATION; TUBERCULOSIS; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84918842939     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00478     Document Type: Article

References (51)

1. Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J (2012) 33(7):829-37. doi: 10.1093/eurheartj/ehr304
2. Musicki B, Ross AE, Champion HC, Burnett AL, Bivalacqua TJ. Posttranslational modification of constitutive nitric oxide synthase in the penis. J Androl (2009) 30(4):352-62. doi:10.2164/jandrol.108.006999
3. Venema RC. Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int Immunopharmacol (2002) 2(13-14):1755-62. doi:10.1016/S1567-5769(02)00185-6
4. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation (2006) 113(13):1708-14. doi:10.1161/CIRCULATIONAHA.105.602532
5. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol (1997) 15:323-50. doi:10.1146/annurev.immunol.15.1.323
6. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res (2002) 12(5-6):311-20. doi:10.1038/sj.cr.7290133
7. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol (2011) 89(6):873-91. doi:10.1189/jlb.1010550
8. Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol (2011) 89(4):557-63. doi:10.1189/jlb.0710409
9. Gross TJ, Kremens K, Powers LS, Brink B, Knutson T, Domann FE, et al. Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses. J Immunol (2014) 192(5):2326-38. doi:10.4049/jimmunol.1301758
10. Schneemann M, Schoeden G. Macrophage biology and immunology: man is not a mouse. J Leukoc Biol (2007) 81(3):579. doi:10.1189/jlb.1106702
11. Schneemann M, Schoedon G. Species differences in macrophage NO production are important. Nat Immunol (2002) 3(2):102. doi:10.1038/ni0202-102b
12. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A (2000) 97(16):8841-8. doi:10.1073/pnas.97.16.8841
13. Obermajer N, Wong JL, Edwards RP, Chen K, Scott M, Khader S, et al. Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Med (2013) 210(7):1433-45. doi:10.1084/jem.20121277
14. Esaki T, Hayashi T, Muto E, Yamada K, Kuzuya M, Iguchi A. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis (1997) 128(1):39-46. doi:10.1016/S0021-9150(96)05976-X
15. Schmidt N, Pautz A, Art J, Rauschkolb P, Jung M, Erkel G, et al. Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes. Biochem Pharmacol (2010) 79(5):722-32. doi:10.1016/j.bcp.2009.10.012
16. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, et al. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A (1994) 91(21):10089-93. doi:10.1073/pnas.91.21.10089
17. Choi HS, Rai PR, Chu HW, Cool C, Chan ED. Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am J Respir Crit Care Med (2002) 166(2):178-86. doi:10.1164/rccm.2201023
18. Huang Z, Hoffmann FW, Fay JD, Hashimoto AC, Chapagain ML, Kaufusi PH, et al. Stimulation of unprimed macrophages with immune complexes triggers a low output of nitric oxide by calcium-dependent neuronal nitric-oxide synthase. J Biol Chem (2012) 287(7):4492-502. doi:10.1074/jbc.M111.315598
19. Perner A, Andresen L, Normark M, Rask-Madsen J. Constitutive expression of inducible nitric oxide synthase in the normal human colonic epithelium. Scand J Gastroenterol (2002) 37(8):944-8. doi:10.1080/003655202760230919
20. Roberts PJ, Riley GP, Morgan K, Miller R, Hunter JO, Middleton SJ. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol (2001) 54(4):293-7. doi:10.1136/jcp.54.4.293
21. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol (1993) 9(4):371-7. doi:10.1165/ajrcmb/9.4.371
22. Lane C, Knight D, Burgess S, Franklin P, Horak F, Legg J, et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax (2004) 59(9):757-60. doi:10.1136/thx.2003.014894
23. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A (1995) 92(17):7809-13. doi:10.1073/pnas.92.17.7809
24. Tang Q, Svensson CI, Fitzsimmons B, Webb M, Yaksh TL, Hua XY. Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. Eur J Neurosci (2007) 25(10):2964-72. doi:10.1111/j.1460-9568.2007.05576.x
25. Ruscheweyh R, Goralczyk A, Wunderbaldinger G, Schober A, Sandkuhler J. Possible sources and sites of action of the nitric oxide involved in synaptic plasticity at spinal lamina I projection neurons. Neuroscience (2006) 141(2):977-88. doi:10.1016/j.neuroscience.2006.04.010
26. Mattila JT, Ojo OO, Kepka-Lenhart D, Marino S, Kim JH, Eum SY, et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol (2013) 191(2):773-84. doi:10.4049/jimmunol.1300113
27. Schmidt HH, Warner TD, Nakane M, Forstermann U, Murad F. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol (1992) 41(4):615-24.
28. Connelly L, Jacobs AT, Palacios-Callender M, Moncada S, Hobbs AJ. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem (2003) 278(29):26480-7. doi:10.1074/jbc.M302238200
29. Evans DM, Ralston SH. Nitric oxide and bone. J Bone Miner Res (1996) 11(3):300-5. doi:10.1002/jbmr.5650110303
30. Wu J, Lin Q, Lu Y, Willis WD, Westlund KN. Changes in nitric oxide synthase isoforms in the spinal cord of rat following induction of chronic arthritis. Exp Brain Res (1998) 118(4):457-65. doi:10.1007/s002210050302
31. Di Girolamo G, Farina M, Riberio ML, Ogando D, Aisemberg J, de los Santos AR, et al. Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum. Br J Pharmacol (2003) 139(6):1164-70. doi:10.1038/sj.bjp.0705315
32. Mungrue IN, Bredt DS. nNOS at a glance: implications for brain and brawn. J Cell Sci (2004) 117(Pt 13):2627-9. doi:10.1242/jcs.01187
33. Lewko B, Zoltowska A, Stepinski J, Kaminski M, Skokowski J, Roszkiewicz A, et al. Nitric oxide synthase type 1 expression in human lung cancer and its relation to p53. Med Sci Monit (2001) 7(2):218-21.
34. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J (1998) 12(10):773-90.
35. Pessanha AP, Martins RA, Mattos-Guaraldi AL, Vianna A, Moreira LO. Arginase-1 expression in granulomas of tuberculosis patients. FEMS Immunol Med Microbiol (2012) 66(2):265-8. doi:10.1111/j.1574-695X.2012.01012.x
36. Brandi ML, Hukkanen M, Umeda T, Moradi-Bidhendi N, Bianchi S, Gross SS, et al. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci U S A (1995) 92(7):2954-8. doi:10.1073/pnas.92.7.2954
37. Lowenstein CJ, Padalko E. iNOS (NOS2) at a glance. J Cell Sci (2004) 117(Pt 14):2865-7. doi:10.1242/jcs.01166
38. Jungi TW, Adler H, Adler B, Thony M, Krampe M, Peterhans E. Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation. Vet Immunol Immunopathol (1996) 54(1-4):323-30. doi:10.1016/S0165-2427(96)05690-5
39. Vitek MP, Brown C, Xu Q, Dawson H, Mitsuda N, Colton CA. Characterization of NO and cytokine production in immune-activated microglia and peritoneal macrophages derived from a mouse model expressing the human NOS2 gene on a mouse NOS2 knockout background. Antioxid Redox Signal (2006) 8(5-6):893-901. doi:10.1089/ars.2006.8.893
40. Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med (1998) 4(9):557-91.
41. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 164(12):6166-73. doi:10.4049/jimmunol.164.12.6166
42. Grimm EA, Ellerhorst J, Tang CH, Ekmekcioglu S. Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis. Nitric Oxide (2008) 19(2):133-7. doi:10.1016/j.niox.2008.04.009
43. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer (1998) 82(10):1897-903. doi:10.1002/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.0.CO;2-O
44. Cianchi F, Cortesini C, Fantappie O, Messerini L, Schiavone N, Vannacci A, et al. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol (2003) 162(3):793-801. doi:10.1016/S0002-9440(10)63876-X
45. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res (2000) 6(6):2408-16.
46. Wolf H, Haeckel C, Roessner A. Inducible nitric oxide synthase expression in human urinary bladder cancer. Virchows Arch (2000) 437(6):662-6. doi:10.1007/s004280000296
47. Brennan PA, Dennis S, Poller D, Quintero M, Puxeddu R, Thomas GJ. Inducible nitric oxide synthase: correlation with extracapsular spread and enhancement of tumor cell invasion in head and neck squamous cell carcinoma. Head Neck (2008) 30(2):208-14. doi:10.1002/hed.20675
48. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res (1998) 58(14):2929-34.
49. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol (2005) 15(4):277-89. doi:10.1016/j.semcancer.2005.04.004
50. Crowell JA, Steele VE, Sigman CC, Fay JR. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther (2003) 2(8):815-23.
51. Fitzpatrick B, Mehibel M, Cowen RL, Stratford IJ. iNOS as a therapeutic target for treatment of human tumors. Nitric Oxide (2008) 19(2):217-24. doi:10.1016/j.niox.2008.05.001